ESMO
SIGN IN MENU
Welcome to the EUROPEAN SOCIETY FOR MEDICAL ONCOLOGY,
the leading European professional organisation for medical oncology.
Sign in
  • About Us
    • ESMO Magazine
    • Who We Are
    • How We Work
    • ESMO Oncology Journals
    • Leading Perspectives
    • Connect with ESMO
    • ESMO 40th Anniversary
    • ESMO Faculty

    Connect with ESMO

    Discover ESMO's new social media dashboard where you will find all your favourite posts and tweets in one place!

    ESMO 40th Anniversary

    #ESMO40 Celebrate with us: watch our anniversary videos, take a virtual stroll through our timeline of 'ESMO firsts' or share your wishes for the future with us…

  • Membership
    • Join ESMO
    • Member Benefits
    • ESMO Booth
    • ESMO in Your Country
    • ESMO Calendar
    • Membership Committee

    Join ESMO

    There are many good reasons to become an ESMO member. Find out why you should join Europe's leading medical oncology society

    Member Benefits

    See the full list of benefits that ESMO members enjoy including access to OncologyPRO, subscription to Annals of Oncology and reduced meeting registration fees

    ESMO Booth

    The ESMO membership booth will be at several oncology meetings in 2018. See where we'll be next!

    ESMO in Your Country

    Our network of National Representatives act as ambassadors of ESMO’s mission in their respective country

    ESMO Calendar

    All the important ESMO dates and deadlines in a single place - don't miss out, update your diaries now!

  • Guidelines
    • Guidelines News
    • Breast Cancer
    • Cancers of Unknown Primary Site
    • Endocrine and Neuroendocrine C...
    • Gastrointestinal Cancers
    • Genitourinary Cancers
    • Gynaecological Cancers
    • Haematological Malignancies
    • Head and Neck Cancers
    • Hereditary Syndromes
    • Lung and Chest Tumours
    • Melanoma
    • Neuro-Oncology
    • Sarcoma and GIST
    • Supportive and Palliative Care
    • Pocket Guidelines & Mobile App
    • ESMO Guidelines Methodology

    Guidelines News

    Keep up to date with news about ESMO guidelines, including the latest CPG publications, updated recommendations, algorithms, pocket guidelines and MCBS grading

    Breast Cancer

    3rd ESO–ESMO International Consensus Guidelines for Advanced Breast Cancer (ABC3) • Prevention and Screening in BRCA Mutation Carriers and Other Breast/Ovarian Hereditary Cancer Syndromes • Primary Breast Cancer

    Cancers of Unknown Primary Site

    Cancers of Unknown Primary Site

    Endocrine and Neuroendocrine Cancers

    Neuroendocrine Bronchial and Thymic Tumours • Neuroendocrine Gastroenteropancreatic Tumours • Adrenal Cancer • Thyroid Cancer

    Gastrointestinal Cancers

    Rectal Cancer • Biliary cancer • Gastric cancer • Oesophageal cancer • Cancer of the pancreas • Metastatic colorectal cancer • Anal cancer • Early colon cancer • Familial risk colorectal cancer • Hepatocellular carcinoma

    Genitourinary Cancers

    Cancer of the Prostate • Bladder Cancer • Renal Cell Carcinoma • Penile Carcinoma • Testicular Seminoma and Non-Seminoma

    Gynaecological Cancers

    Cervical cancer • Endometrial cancer • Gestational trophoblastic disease • Newly diagnosed and relapsed epithelial ovarian carcinoma • Non-epithelial ovarian cancer

    Haematological Malignancies

    Chronic myeloid leukaemia • Newly diagnosed and relapsed mantle cell lymphoma • Multiple myeloma • Newly diagnosed and relapsed follicular lymphoma • Extranodal diffuse large B-cell lymphoma and primary mediastinal B-cell lymphoma • Acute lymphoblastic leukaemia • Peripheral T-cell lymphomas • Diffuse large B cell lymphoma • Chronic lymphocytic leukaemia • Hairy cell leukaemia • Philadelphia chromosome-negative chronic myeloproliferative neoplasms • Myelodysplastic syndromes • Hodgkin's lymphoma • Primary cutaneous lymphoma • Acute myeloblastic leukaemia in adult patients • Waldenstrom's macroglobulinaemia • Gastric marginal zone lymphoma of MALT type

    Head and Neck Cancers

    Nasopharyngeal Cancer • Squamous-Cell Carcinoma of the Head and Neck

    Hereditary Syndromes

    Prevention and Screening in BRCA Mutation Carriers and Other Breast/Ovarian Hereditary Cancer Syndromes

    Lung and Chest Tumours

    Early and locally advanced non-small-cell lung cancer • Metastatic non-small-cell lung cancer • Thymic epithelial tumours • Malignant pleural mesothelioma • Small-cell lung cancer

    Melanoma

    Cutaneous Melanoma

    Neuro-Oncology

    EANO and ESMO guidelines on leptomeningeal metastasis from solid tumours • High-grade malignant glioma 

    Sarcoma and GIST

    Soft Tissue and Visceral Sarcomas • Bone Sarcomas • Gastrointestinal Stromal Tumours

    Supportive and Palliative Care

    Management of anaemia and iron deficiency in patients with cancer • Management of infusion reactions to systemic anticancer therapy • Management of toxicities from immunotherapy • Management of febrile neutropaenia • MASCC and ESMO consensus guidelines for the prevention of chemotherapy and radiotherapy-induced nausea and vomiting • Treatment of dyspnoea in advanced cancer patients • Central venous access in oncology • Management of oral and gastrointestinal mucosal injury • Management of refractory symptoms at the end of life and the use of palliative sedation • Advanced care planning in palliative care • Bone health in cancer patients • Cancer, fertility and pregnancy • Management of chemotherapy extravasation • Cardiovascular toxicity induced by chemotherapy, targeted agents and radiotherapy •  Management of cancer pain • Management of venous thromboembolism in cancer patients

    Pocket Guidelines & Mobile App

    Download the new version of our App with the latest Pocket Guidelines for professionals and Guides for Patients

    ESMO Guidelines Methodology

    To assist those using and/or evaluating the ESMO Guidelines, download the methodology here

  • Conferences
    • ESMO Update for Practising Onc...
    • World GI 2018 – Gastrointestin...
    • ESMO-ESO Course on Medical Onc...
    • ESMO Academy 2018
    • ESMO-ESO Course on Medical Onc...
    • MAP 2018 – Molecular Analysis...
    • ESMO 2018 Congress
    • EMUC 2018 – Urological Cancers
    • ESMO Asia 2018 Congress
    • ESMO Immuno-Oncology Congress...
    • TAT 2019 – International Congr...
    • ELCC 2019 - European Lung Canc...
    • ESMO Breast Cancer 2019
    • ESMO 2019 Congress
    • Advanced Courses
    • Preceptorship Courses
    • Workshops & Courses
    • Oncology Conferences Calendar
    • ESMO Events App
    • Past Conferences
    • ELCC 2018 – Lung Cancer

    ESMO Update for Practising Oncologists 2018

    The ESMO Update for Practising Oncologists 2018 will be held in Lugano, Switzerland. 27-29 April 2018

    World GI 2018 – Gastrointestinal Cancer

    ESMO World Congress on Gastrointestinal Cancer 2018: 20 - 23 June 2018, Barcelona, Spain

     

    ESMO-ESO Course on Medical Oncology for Medical Students Valencia 2018

    The course will take place in Valencia, Spain; 19-24 July 2018

    ESMO Academy 2018

    The 4th ESMO Academy will take place: 1-3 September 2018, Oxford, UK

    ESMO-ESO Course on Medical Oncology for Medical Students Naples 2018

    The course will take place in Naples, Italy; 2-7 September 2018

    MAP 2018 – Molecular Analysis for Personalised Therapy

    14-15 September 2018, Paris, France

    ESMO 2018 Congress

    Save the date for ESMO 2018. 19-23 October 2018, Munich, Germany

    EMUC 2018 – Urological Cancers

    10th European Multidisciplinary Congress on Urological Cancers - EMUC 2018: 8-11 November 2018, Amsterdam, The Netherlands

     

    ESMO Asia 2018 Congress

    Join us in Singapore for ESMO Asia 2018. 23-25 November 2018

    ESMO Immuno-Oncology Congress 2018

    Join us in Geneva, Switzerland, 13-16 December 2018

    TAT 2019 – International Congress on Targeted Anticancer Therapies

    TAT 2019 will take place in Paris, France. 25-27 February 2019

    ELCC 2019 - European Lung Cancer Congress

    Join us in Geneva, Switzerland, 10-13 April 2019

    ESMO Breast Cancer 2019

    Save the date for ESMO Breast Cancer 2 – 4 May 2019, Berlin, Germany

    ESMO 2019 Congress

    Save the date for ESMO 2019. 27 September – 1 October 2019, Barcelona, Spain

    Advanced Courses

    The ESMO Advanced Courses aim to address specific therapeutic challenges in patient management in different tumour settings.

    Preceptorship Courses

    Apply now to join one of our Preceptorship courses!

     

    Workshops & Courses

    ESMO fosters the advancement of cancer research by supporting clinical trials workshops to inspire young oncologists from different disciplines across the globe to become the next generation of active researchers.

    Oncology Conferences Calendar

    View the complete list of ESMO oncology conferences including partnership meetings

    ESMO Events App

    If you're attending an ESMO event make sure you download our Events App for fast access to programmes, floor plans & much more!

    Past Conferences

    Access information and reports from past ESMO events

    ELCC 2018 – Lung Cancer

    ELCC was held in Geneva, Switzerland, 11-14 April 2018

     

  • Career Development
    • Young Oncologists Corner
    • Oncology Fellowships
    • Jobs in Oncology
    • Awards
    • Global Curriculum in Medical O...
    • ESMO Examination
    • Recertification & CME
    • Women for Oncology
    • Leaders Generation Programme
    • Childcare Service

    Young Oncologists Corner

    Addressing the daily needs of ESMO young oncologists

    Oncology Fellowships

    Invest in your future and the future of cancer care. Learn more about our Oncology Fellowship Programme.

    Jobs in Oncology

    The latest oncology jobs can be found here, including information on how to post a job

    Awards

    ESMO has developed a number of awards that recognise excellence in the field of oncology. Nominate your candidate for the 2018 ESMO Awards

     

    Global Curriculum in Medical Oncology

    The 2016 edition of ESMO / ASCO Recommendations for a Global Curriculum in Medical Oncology and the 2017 edition of the associated Log Book are now available 

    ESMO Examination

    Register now for the 2018 ESMO examination – a valuable assessment tool for practicing medical oncologists and for medical oncologists in training

    Recertification & CME

    If you’ve already sat the ESMO exam, then take a look at our CME opportunities

    Women for Oncology

    Advancing the careers of female oncologists to become the leaders of tomorrow

    Leaders Generation Programme

    An inspiring programme for future ESMO leaders

    Childcare Service

    Attend sessions at Congress knowing your child is having fun and in safe hands

  • Research
    • EU Calls for Proposal
    • How to Apply For EU Grants
    • Other Research Funding Opportu...
    • Training and Events
    • Regulatory Information
    • Research Groups, Databases and...
    • About the Grant Schemes

    EU Calls for Proposal

    An ESMO pre-selected listing of the most recent EU research funding opportunities

    How to Apply For EU Grants

    Relevant information and tools to guide you through various EU grant application procedures

    Other Research Funding Opportunities

    A selection of funding organisations to assist you in your projects

    Training and Events

    What`s available in terms of clinical research training and educational events

    Regulatory Information

    Clear, relevant information on EU clinical trials and data protection legislation

    Research Groups, Databases and Tools

    Useful links to partners and tools for your research projects

    About the Grant Schemes

    General European grant scheme information highlighting the main objectives, available funding and target audiences

  • Patients
    • Patient Guides
    • Personalised Medicine Explained
    • Getting the Most out of Your O...
    • Designated Centres of Integrat...
    • Patient Advocacy Track
    • Advocacy in Action
    • Designated Centres Working Group

    Patient Guides

    Guides for Patients are designed to assist patients, their relatives and caregivers to better understand the nature of different types of cancer and evaluate the best available treatment choices

    Personalised Medicine Explained

    Video interviews and articles designed to help patients, policy makers and other non-medical professionals better understand the principles of personalised cancer medicine

    Getting the Most out of Your Oncologist

    Now available in Romanian, our Guide for Patients with Advanced Cancer is designed for patients, their family members and oncologists.

    Designated Centres of Integrated Oncology and Palliative Care

    The ESMO Designated Centres of Integrated Oncology and Palliative Care accreditation programme recognises cancer centres which provide comprehensive services in supportive and palliative care as part of their routine care.

    Patient Advocacy Track

    The ESMO Patient Advocacy Track encourages communication between patients, families, oncologists and healthcare professionals.

  • Policy
    • Recognition and Status of Medi...
    • Political Initiatives
    • Position Statements & Recommen...
    • Magnitude of Clinical Benefit...
    • Anti-Cancer Medicines Availabi...
    • Global Opioid Policy Initiative
    • Cancer Prevention Initiatives
    • Rare Cancers Europe
    • EFPIA Disclosure Code
    • Policy News

    Recognition and Status of Medical Oncology

    Medical oncology is included among the medical specialities covered by the European Commission Directive 2005/36/EC.

    Political Initiatives

    ESMO’s political initiatives aim to promote the profession of medical oncology and keep cancer policy high on the European healthcare agenda.

    Position Statements & Recommendations

    ESMO position statements and recommendations can be downloaded here.

    Magnitude of Clinical Benefit Scale

    The ESMO-Magnitude of Clinical Benefit Scale – promoting clear and unbiased communication about the benefit of cancer treatments

    Anti-Cancer Medicines Availability

    The objective of this ESMO-led study is to provide health authorities with data on the availability of licensed anti-neoplastic medicines

    Global Opioid Policy Initiative

    ESMO has endorsed the 'Prague Charter: Relieving suffering' set up by the European Association for Palliative Care (EAPC) & other organisations

    Cancer Prevention Initiatives

    ESMO seeks to eradicate cancer at its earliest stages through effective cancer prevention awareness and advocacy campaigns.

    Rare Cancers Europe

    Rare Cancers Europe is a multi-stakeholder initiative dedicated to putting rare cancers firmly on the European policy agenda.

    EFPIA Disclosure Code

    Information about the EFPIA Disclosure Code which comes into effect 1 January 2015

    Policy News

    News from the ESMO Policy section

  • OncologyPRO

    Welcome to OncologyPRO, the home of ESMO’s educational and scientific resources, with Guidelines, a comprehensive list of E-Learning modules, Factsheets on biomarkers, slides and webcasts from our educational programme, and more... to support continuing medical education and daily practice!

    OncologyPRO offers ESMO members exclusive content such as ESMO’s Congresses webcasts, daily Oncology news, accrual of CME points, free downloads of ESMO’s educational books and a direct access to Annals of Oncology.

Clinical Practice Guidelines Slides Set banner

A new way of viewing and using the ESMO Clinical Practice Guideline: discover ESMO Guidelines Slide Sets!

Website maintenance

You may experience disruptions while logging in on our website

Annals of Oncology Hiring

The Executive Board of ESMO is seeking applications for the position of Editor-in-Chief of Annals of Oncology

Student Course on Medical Oncology Naples 2018 - banner

Medical students: Naples course application deadline is 30 April 2018!

ESMO Asia 2018 - Submit Your Abstract banner

Give visibility to your scientific research! Abstract submissions now open.

Top Story

ESMO Perspectives Magazine

 

Latest edition of ESMO Perspective - spotlight on practice!

Read more
ESMO Open

ESMO Open

Our open access, online journal, ESMO Open is now listed in Pubmed Central, only 10-months after launch. Learn more about the journal!

Read the Editor's choice articles

view more
Join the European Society for Medical Oncology

Join ESMO

There are many good reasons to become an ESMO member. Find out why you should join Europe's leading medical oncology society

view more
Annals of Oncology

Annals of Oncology

ESMO’s flagship scientific journal, Annals of Oncology, publishes editorials, reviews, original articles and letters related to oncology

 

view more
ELCC 2018 block

ELCC 2018 European Lung Cancer Congress

Resources from ELCC 2018 European Lung Cancer Congress can be accessed by ESMO members and event attendees

view more

Video

Stefan Rauh, Chair of the second edition of the ESMO Update for Practising Oncologists, explains the changes in this interactive meeting, what is new for 2018 and why practising oncologists should participate.

More ESMO videos

Latest News

  • 20 Apr 2018

    FDA Approves Osimertinib for First-Line Treatment of Metastatic NSCLC With Most Common EGFR Mutations

    Approval is based on results from FLAURA study conducted in patients with EGFR exon 19 deletion or exon 21 L858R mutation

  • 19 Apr 2018

    MAP 2018: Registration

    Registration for MAP 2018 – Molecular Analysis for Personalised Therapy is open! Join us in Paris, France, 14-15 September 2018.

  • 19 Apr 2018

    CheckMate 227 Reveals Tumour Mutational Burden as an Important and Independent Biomarker in Advanced NSCLC

    First-line treatment with nivolumab/ipilimumab combination associated with longer PFS than with chemotherapy in patients with high TMB, irrespective...

  • 18 Apr 2018

    FDA Approves Nivolumab/Ipilimumab Combination for Intermediate or Poor-Risk Advanced RCC

    Approval is based on the results from CheckMate 214

  • 18 Apr 2018

    ESMO Immuno-Oncology Congress 2018: Abstracts

    Abstract submission for ESMO Immuno-Oncology Congress 2018 is open. Submit your abstract now!

  • 17 Apr 2018

    FDA Finalises Guidances to Accelerate the Development of Reliable, Beneficial NGS-Based Tests

    The agency is leveraging new tools and policies to advance the creation of innovative genetic and genomic-based tests and help ensure the validity of...

all news

ESMO Conferences

  • 27 Apr

    ESMO Update for Practising Oncologists 2018

    Lugano, Switzerland
    27 Apr - 29 Apr 2018

  • 04 May

    ESMO Preceptorship on Immuno-Oncology 2018: Lugano

    Lugano, Switzerland
    04 May - 05 May 2018

  • 11 May

    ESMO Preceptorship on AYA Malignancies 2018: Lugano

    Lugano, Switzerland
    11 May - 12 May 2018

  • 18 May

    ESMO Preceptorship on Colorectal Cancer 2018: Valencia

    Valencia, Spain
    18 May - 19 May 2018

  • 22 May

    ESMO Preceptorship on Head & Neck Cancer 2018: Zurich

    Zurich, Switzerland
    22 May - 23 May 2018

  • 20 Jun

    World GI 2018 – Gastrointestinal Cancer

    Barcelona, Spain
    20 Jun - 23 Jun 2018

More ESMO conferences

OncologyPRO News

  • Novel Strategies Tested To Boost Checkpoint Inhibitor Efficacy
  • Neoadjuvant Nivolumab Induces Pathological Response In Early-Stage NSCLC
  • First-Line Pembrolizumab Plus Chemotherapy May Extend Metastatic NSCLC Survival
  • Targeted Therapy Reported For RET-Altered Tumours
  • Adjuvant Pembrolizumab May Improve High-Risk Stage III Melanoma RFS
logo-onc-pro
  • About Us
  • Press Office
  • President's Letter
  • Terms of Use
  • Links
  • Sitemap
  • Privacy Policy
  • Contact Us
ico-social_tw ico-social_fb ico-social_gplus ico-social_yt ico-social_rss ico-social_in

ESMO is a Swiss-registered not-for-profit organisation. All funding for this site is provided directly by ESMO. Via L. Taddei 4, 6962 Viganello - Lugano - CH © Copyright 2018 European Society for Medical Oncology All rights reserved worldwide.

Scroll